Q32 Bio Inc.

Get Full Access

Description

  • location

    Headquarters:1 Broadway , Cambridge, Massachusetts, United States

    More
  • Q32 Bio Inc. phone

    Phone Number: +1 503-807-4350

  • Q32 Bio Inc. website

    Website:

  • Q32 Bio Inc. employees

    Employees:13

  • Q32 Bio Inc. revenue

    Revenue:$10 - 50M

  • Q32 Bio Inc. legal name

    Legal Name:Q32 Bio Inc.

  • Q32 Bio Inc.'s Social Media

    Q32 Bio Inc. linkedin
  • done Is this data correct?
  • |  NAICS Code: 541713  |

    Show More
Person level website identification

Vice President, Regulatory Affairs for Q32 Bio Inc.

Debra Segal

Vice President, Regulatory Affairs

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Debra Segal

Vice President, Regulatory Affairs

Joel Scherer

Vice President, Clinical Development, Immunotherapeutics

Stefan Wawersik

Vice President Of Research

Eric Bell

Vice President Finance And Controlling

Charles Romano

Vice President Clinical Development

Frequently Asked Questions regarding Q32 Bio Inc.

  • Where are Q32 Bio Inc.'s Headquarters?

    Q32 Bio Inc.'s Headquarters are in 1 Broadway ,Cambridge,Massachusetts,United States

  • What is Q32 Bio Inc.'s phone number?

    Q32 Bio Inc.'s phone number is +1 503-807-4350

  • What is Q32 Bio Inc.'s Revenue?

    Q32 Bio Inc.'s revenue is $10 - 50M

  • What is Q32 Bio Inc.'s NAICS code?

    Q32 Bio Inc.'s NAICS code is 541713

  • How many employees are working in Q32 Bio Inc.

    Q32 Bio Inc. has 13 employees

  • What is Q32 Bio Inc.'s Industry?

    Q32 Bio Inc. is in the industry of Biotechnology

  • Who is Q32 Bio Inc.'s Vice President, Regulatory Affairs?

    Q32 Bio Inc.'s Vice President, Regulatory Affairs is Debra Segal

  • Who is Q32 Bio Inc.'s Vice President, Clinical Development, Immunotherapeutics?

    Q32 Bio Inc.'s Vice President, Clinical Development, Immunotherapeutics is Joel Scherer

Company Directory